Cervical Squamous Cell Carcinoma Not Otherwise Specified
📧 Sign up to get email alerts when something new happens for Cervical Squamous Cell Carcinoma Not Otherwise Specified.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-02-21Clinical Trial Update: Atezolizumab and Bevacizumab in Treating Patients With Recurrent, Persistent, or Metastatic Cervical Cancer [Phase 2]
Phase 2 trial evaluating atezolizumab and bevacizumab in patients with recurrent, persistent, or metastatic cervical cancer; results availab…
-
CLINICAL_TRIALS trial_result · 2022-11-07Clinical Trial Update: Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer [Phase 3]
Phase 3 trial comparing cisplatin and radiation with or without carboplatin and paclitaxel in locally advanced cervical cancer has completed…
-
CLINICAL_TRIALS trial_result · 2020-09-11Clinical Trial Update: Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer [Phase 2]
Phase 2 trial updating vaccine therapy for persistent or recurrent cervical cancer has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-01-10Clinical Trial Update: Docetaxel in Treating Patients With Persistent or Recurrent Cervical Cancer [Phase 2]
Phase 2 trial evaluating docetaxel for persistent or recurrent cervical cancer has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-04Clinical Trial Update: Brivanib Alaninate in Treating Patients With Persistent or Recurrent Cervical Cancer [Phase 2]
Phase 2 trial of brivanib alaninate in persistent or recurrent cervical cancer has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.